EU Exports to New Zealand1 New Zealand Exports to EU

Trade conditions Equivalence Special conditions Action Trade conditions Equivalence Special conditions Action

EU standards NZ standards NZ standards EU standards

27. Horizontal issues

Water 98/83/EC Animal Products Act 1999 Health Act 1956 Yes (1) Animal Products Act 1999 98/83/EC Yes (1)

Residues Residue monitoring — Red meat species 96/22/EC 96/23/EC Animal Products Act 1999 Food Act 1981 Yes (1) Animal Products Act 1999 96/22/EC 96/23/EC Yes (1)

— Other species other products Yes (3) Yes (3)

Certification Systems 96/93/EC Animal Products Act 1999 Yes (1) Equivalence status applies to all animals and animal product commodities accorded both animal and public health equivalence “Yes (1)” as appropriate. Animal Products Act 1999 92/118/EEC 96/93/EC 2002/99/EC Regulations (EC) No 852/2004 (EC) No 853/2004 (EC) No 854/2004 (EC) No 2074/2005 (EC) No 1251/2008 (EC) No 1069/2009 (EU) No 142/2011 Yes (1) Equivalence status applies to animals and animal product commodities listed with “Yes (1)” equivalence status under entry Numbers 3, 4A, 4C, 4D, 5A, 5C, 5D, 6A, 6C, 6D, 7A, 7B, 7C, 7D, 7E, 7H, 9, 10, 12, 15, 16, 17, 19, 21 and 23 When the official health certificate is issued after the departure of the consignment, it shall include reference to the appropriate Eligibility Document (ED), date of issuance of the eligibility document that supports the official health certificate, the date of departure of the consignment and the date of signing of the official health certificate. New Zealand shall inform the border inspection post of arrival of any certification problem after departure from New Zealand.

Re-exports of imported animal products 96/93/EC Animal Products Act 1999 Food Act 1981 Biosecurity Act 1993 Yes (1) Animal products may be derived or partly derived from complying animal product(s) which originated in a third country/countries and establishment(s) eligible for trade with the EU and New Zealand. Animal Products Act 1999 Food Act 1981 Biosecurity Act 1993 96/93/EC Yes (1) Animal products may be derived or partly derived from complying animal product(s) which originated in a third country/countries and establishment(s) eligible for trade with the EU and New Zealand.

Microbiological monitoring/test system (3) (4) including: test methods, standards for sampling and preparation, and regulatory actions Regulations (EC) No 852/2004 (EC) No 853/2004 (EC) No 854/2004 (EC) No 2073/2005 Animal Products Act 1999 Yes (1) Animal Products Act 1999 Regulations (EC) No 852/2004 (EC) No 853/2004 (EC) No 854/2004 (EC) No 2073/2005 Yes (1)

Establishment Listing Systems (5) Regulations (EC) No 178/2002 (EC) No 882/2004 (EC) No 852/2004 (EC) No 854/2004 Animal Products Act 1999 Yes (1) Animal Products Act 1999 Regulations (EC) No 178/2002 (EC) No 882/2004 (EC) No 852/2004 (EC) No 854/2004 Yes (1) Equivalence status applies to all animal product commodities accorded public health equivalence “Yes (1)” as laid down in this Annex. Procedures for establishment listings for non “Yes (1)” commodities to be reviewed.

28. Miscellaneous certification provisions: Attestations are to appear on the public or animal health certificate.

Issue Certification provisions

Q-fever New Zealand is recognised as free of Q-fever. For trade from the EU to NZ in bovine semen and embryos, the Member State competent authority shall certify that: To the best of my knowledge and as far as I can ascertain, the donors have never been confirmed positive for Q-fever; AND For bovine semen EITHER The donors were subjected to a complement fixation test (CFT) (negative being no fixation of complement at dilution of 1:10 or higher) or ELISA test for Q-fever, on a sample collected between 21 to 120 days after each semen collection period (a period of 60 days or less) for export to New Zealand, with negative results. OR An aliquot of semen from each collection for export to New Zealand was tested using a laboratory validated Q-fever PCR test which is in accordance with the methods described in the Q-fever Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. AND For bovine embryos EITHER The donors were subjected to a complement fixation test (CFT) (negative being no fixation of complement at dilution of 1:10 or higher) or ELISA test for Q-fever, on a sample collected between 21 to 120 days after each embryo collection period for export to New Zealand, with negative results. OR A sample of embryos/oocytes and collection and/or washing fluids from each collection for export to New Zealand was/were tested using a laboratory validated Q-fever PCR test which is in accordance with the methods described in the Q-fever Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

BVD type II New Zealand is recognised as free of Bovine viral diarrhoea virus (BVDV): Type II. For trade from the EU to NZ in bovine embryos, the Member State competent authority shall certify that: EITHER The donor animal was subjected to an antigen detection ELISA or virus isolation test for BVDV, with a negative result within thirty (30) days prior to entry into the herd of origin and has been in the herd of origin for more than six (6) months prior to embryo collection for this consignment and has remained isolated from other animals that have not been tested negative. OR From the first embryo collection taken from the donor animal for this consignment, either a pooled sample of non-viable oocytes/embryos and washing fluid (as per the OIE Code Chapter for in vivo derived embryos) or an embryo, has been subject to either virus isolation test or PCR test for BVDV with negative results.

Bluetongue New Zealand is recognised as free of Bluetongue and Epizootic Haemorrhagic Disease. For trade from the EU to NZ in bovine semen, the Member State competent authority shall certify that: The bovine semen complies with the provisions of the Bluetongue Chapter of the OIE Code mutatis mutandis.

IBR For trade in live bovine animals from NZ to Member States or regions thereof listed in Annex I to Decision 2004/558/EC New Zealand shall certify in accordance with Article 2 of Commission Decision 2004/558/EC, and to Member States or regions thereof listed in Annex II to Decision 2004/558/EC New Zealand shall certify in accordance with Article 3 of Decision 2004/558/EC. This attestation shall appear on the health certificate according to Commission Regulation (EU) No 206/2010.

BSE EU exports of products containing bovine, ovine or caprine materials to NZ (in addition to full compliance with all other relevant EU standards) This product does not contain and is not derived from bovine, ovine and caprine materials other than those derived from animals born, continuously reared and slaughtered in the European Union and which has been produced in full compliance with Regulations of the European Parliament and the Council (EC) No 999/2001 and (EC) No 1069/2009 as applicable. Note: Products which contain bovine, ovine or caprine materials other than from those derived from animals born, continuously reared and slaughtered in the European Union are required to have that component certified in accordance with the relevant, additional third country provisions in the applicable NZ certification decision.

BSE NZ exports of products containing bovine, ovine or caprine materials to the EU For human consumption — fresh meat, minced meat and meat preparations, meat products, treated intestines, rendered animal fats, greaves, and gelatine: (a) The country or region is classified in accordance with Article 5(2) of Regulation (EC) No 999/2001 as a country or region posing a negligible BSE risk; (b) The animals from which the products of bovine, ovine and caprine animal origin were derived were born, continuously reared and slaughtered in a country with a negligible BSE risk. For by-products — rendered fats, pet food, blood products, processed animal protein, bones and bone products, category 3 material, and gelatine: The animal by-product does not contain and is not derived from bovine, ovine and caprine materials other than those derived from animals born, continuously reared and slaughtered in a country or region classified as posing a negligible BSE risk by a decision in accordance with Article 5(2) of Regulation (EC) No 999/2001.

PRRS For trade from the EU to NZ in pig meat, the Member State competent authority shall certify that: EITHER (i) derived from animals that were continuously resident since birth in Finland or Sweden, which is free of Porcine Reproductive and Respiratory Syndrome; OR (ii) cooked to one of the following core temperature/times: 56 degrees Celsius for 60 minutes; 57 degrees Celsius for 55 minutes; 58 degrees Celsius for 50 minutes; 59 degrees Celsius for 45 minutes; 60 degrees Celsius for 40 minutes; 61 degrees Celsius for 35 minutes; 62 degrees Celsius for 30 minutes; 63 degrees Celsius for 25 minutes; 64 degrees Celsius for 22 minutes; 65 degrees Celsius for 20 minutes; 66 degrees Celsius for 17 minutes; 67 degrees Celsius for 15 minutes; 68 degrees Celsius for 13 minutes; 69 degrees Celsius for 12 minutes; or 70 degrees Celsius for 11 minutes; OR (iii) cured where the product has been subjected to a procedure which ensures the meat meets one of the following requirements: reached a pH of 5 or lower; or was fermented (lactic curing) to a pH of 6,0 or lower and age-cured/ripened for at least 21 days; or qualified for official certification as Prosciutto di Parma or an equivalent 12 month curing process; OR (iv) prepared as consumer-ready cuts packaged for direct retail sale, not including minced (ground) meat, not including the head and neck, not exceeding 3 kg per package, with the following tissues removed: axillary, medial and lateral iliac, sacral, iliofemoral (deep inguinal), mammary (superficial inguinal), superficial and deep popliteal, dorsal superficial cervical, ventral superficial cervical, middle superficial cervical, gluteal and ischiatic lymph nodes; and any other macroscopically visible lymphatic tissue (i.e. lymph nodes and lymphatic vessels) encountered during processing; OR (v) none of the above (Note: These products need to be processed in New Zealand prior to being given a biosecurity clearance.)

Aujeszky's disease For trade in live pigs from NZ to Member States or regions thereof listed in Annex I and Annex II to Decision 2008/185/EC New Zealand shall certify in accordance with Decision 2008/185/EC. This attestation shall appear on the health certificate according to Commission Regulation (EU) No 206/2010.

CSF — feral pigs only For trade from the EU to NZ the Member State competent authority shall certify that the products were derived from areas free from CSF in the feral porcine population for the preceding 60 days. This attestation shall appear on the health certificate: “The product herein described was derived from wild pigs which were sourced from areas free from classical swine fever in the feral porcine population for the preceding 60 days.”

Live bees/bumble bees For trade from NZ to the EU, the health certificate(s) for live bees/bumble bees shall bear the following attestation: The bees/bumble bees (1), herein described: (a) come from a breeding apiary, which is supervised and controlled by the competent authority; (b) in the case of honey bees, hives come from an area which is not subject to any restrictions associated with an occurrence of American foul brood (the period of prohibition has been continued for at least 30 days following the last recorded case and the date of which all hives within a radius of three kilometres have been checked by the competent authority and all infected hives burned or treated and inspected to the satisfaction of the said competent authority); (c) are from hives or come from hives or colonies (in the case of bumble bees), which were inspected immediately prior to dispatch (normally within 24 hours) and show no clinical signs or suspicion of disease including infestations affecting bees. The packaging material, queen cages, accompanying products and food are new and have not been in contact with diseased bees or brood-combs, and all precautions have been taken to prevent contamination with agents causing diseases or infestations of bees. (1) Delete as appropriate

Colours for sanitary stamps Regulation (EC) No 1333/2008 prescribes the colours that could be used for sanitary stamps.

Salmonella For trade from NZ to Sweden and Finland The health certificate(s) for live animals and animal products listed below, shall bear the appropriate attestation set out in the corresponding legislation, if they are imported for consignment to either Sweden or Finland: For table eggs for human consumption New Zealand shall certify in accordance with Commission Regulation (EC) No 1688/2005 For live poultry for slaughter New Zealand shall certify in accordance with Annex A to Council Decision 95/410/EC For breeding poultry New Zealand shall certify in accordance with Annex II to Commission Decision 2003/644/EC For day old chicks New Zealand shall certify in accordance with Annex III to Commission Decision 2003/644/EC For laying hens New Zealand shall certify in accordance with Annex II to Commission Decision 2004/235/EC For fresh meat covered by Regulation (EC) No 1688/2005, the following attestation is to be added “The fresh meat has been subject to microbiological testing for salmonella as provided for in Regulation (EC) No 1688/2005 by sampling in the establishment of origin of this meat.”

Salmonids For trade from the EU to NZ The consignment contains only beheaded, gilled, gutted and sexually immature Salmonids of the genera Onchorhynchus, Salmo or Salvelinus.

Eggs/roes For trade from the EU to NZ Must be treated to render eggs/roe non-viable, commercially packaged and shelf stable.

Thermised cheeses For trade from the EU to NZ The thermised cheese has a moisture content of less than 39 % and pH less than 5,6. The milk used to produce this cheese was rapidly heated to at least 64,5 °Celsius for 16 seconds. The cheese was stored at not less than 7° Celsius for 90 days.

29. Mutually agreed disease control measures

29.A. Mutually agreed disease status for specific diseases

Rabies New Zealand, UK, Malta, Ireland and Sweden are recognised as free of rabies

Equine infectious anemia New Zealand is recognised as free of EIA

Brucellosis New Zealand is recognised as free of Brucella abortus and B. mellitensis

Q-fever New Zealand is recognised as free of Q-fever

BVD type II New Zealand is recognised as free BVD type II

Bluetongue and EHD New Zealand is recognised as free of Bluetongue and EHD EU makes a submission to NZ for EHD freedom

Small hive beetle New Zealand and the EU are recognised as free of small hive beetle

Tropilaelaps mite New Zealand and the EU are recognised as free of tropilaelaps mite

No 29.B. Mutually agreed disease control measures in the event of the occurrence of a specific disease Official health certificates shall, in accordance with Section 1(b) of Annex VII to the Agreement, bear the relevant additional attestation(s) listed under Chapter 29 of this Annex.

General Attestation for all commodities: The commodity herein described was kept separate from all other commodities that did not meet the requirements during all stages of production, storage and transport and all necessary precautions were taken to prevent contamination of the commodity with any potential source of [insert relevant disease noted in the disease column below] virus.

Disease specific attestation: The commodities listed in Chapter 29 i) to xxx) shall in addition to the General Attestation (noted above) for all commodities bear the relevant disease attestation(s) below:

Commodity Disease Disease Attestation Number*) Optional attestations need only be applied to the certificate when applicable.

(i) Milk and Milk Products: 8.0 13.0 FMD The milk/milk products herein described: EITHER 1*) have undergone sterilisation of at least F03. OR 2*) have undergone an ultra-high temperature (UHT) treatment at 132 °C for at least 1 second. OR 3*) had a pH of less than 7,0 prior to undergoing a high temperature — short time pasteurisation (HTST) treatment at 72 °C for 15 seconds. OR 4*) had a pH of more than 7,0 prior to undergoing a double high temperature — short time pasteurisation (HTST) treatment at 72 °C for 15 seconds. OR 5*) have been subjected to high temperature — short time pasteurisation (HTST) combined with the lowering of pH below 6 for one hour. OR 6*) have been subjected to high temperature — short time pasteurisation (HTST) combined with additional heating to 72 °C combined with desiccation or an equivalent validated and approved drying/desiccation process that achieves at minimum an equivalent thermal effect of 72 °C for 15 seconds.

(ii) Meat (including minced meat) and meat preparations from bi-ungulates excluding head, feet, viscera and meat from swine ( suidae ): 4.A 4.C 5.A 5.C FMD The [insert relevant commodity] herein described (excluding feet, head and viscera) was: 1. derived from animals that have been subjected to ante-mortem and post-mortem inspections and have been found free of any sign suggestive of FMD; 2. derived from deboned carcasses from which the offal and major lymphatic glands have been removed; 3. subject to maturation at a temperature above + 2 °C for at least 24 hrs and reached a pH value of below 6 when tested in the middle of the longissimus dorsi muscle after maturation and before deboning; 4. was not derived from animals slaughtered or processed in an establishment located within a designated protection or surveillance zone, 5. Meat sourced from animals within the protection and surveillance zones is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.

(iii) Meat (including minced meat) and other animal products (including offal) derived from bi-ungulates including swine ( suidae ): 4.A 4.C 5.A 5.C 7.A 7.B 7.C 7.D 7.E 7.F 7.G 11.E FMD The [insert relevant commodity] herein described was: I) derived from animals that have been subjected to ante-mortem and post-mortem inspection and have been found free of any sign suggestive of FMD; AND EITHER 2*) derived from animals slaughtered 21 days prior to the estimated date of earliest infection in the territory; and not derived from animals slaughtered or processed in an establishment located within a designated protection or surveillance zone. OR 3*) derived from animals that have been resident on a holding for at least 21 days and were identified so as to allow the tracing of the holding of origin; but not derived from animals resident in holdings within a protection or surveillance zone; and the commodity has been clearly identified and detained under official supervision for at least 7 days and was not released until any suspicion of infection with the foot-and-mouth disease virus on the holding of origin has been officially ruled out at the end of the detention period; AND 4. Meat sourced from animals within the protection and surveillance zones is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.

(iv) Meat and meat preparations from Poultry (including turkeys): 4.B 4.C 5.B 5.C HPNAI — Notifiable in accordance with OIE Terrestrial Animal Health Code criteria The [insert relevant commodity] herein described was derived from animals that: EITHER 1*) have been sourced from a holding situated outside a protection or a surveillance zone; and all meat sourced from animals within the protection and surveillance zones is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.; OR 2*) have been sourced from a holding within a surveillance zone but outside a protection zone and have been tested to give a 95 % probability of detecting a 5 % prevalence of HPNAI infection not more than 7 days prior to slaughter using virus detection tests, and/or serological tests, with negative results; and have been slaughtered in a designated establishment which has not processed poultry infected with HPNAI since last cleaned and disinfected, and have been subjected to ante-mortem and post-mortem examinations and have shown no signs suggestive of HPNAI; and all meat sourced from animals within the protection zone is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment. OR 3*) were processed on a date at least 21 days before the estimated date of earliest infection.

(v) Meat and meat preparations from Poultry (including turkeys): 4.B 4.C 5.B 5.C LPNAI Notifiable in accordance with OIE Terrestrial Animal Health Code criteria The [insert relevant commodity] herein described was derived from animals that; 1. have been sourced from a holding in which there has been no evidence of LPNAI during the past 21 days; 2. have been slaughtered in an approved establishment which has not processed poultry infected with LPNAI since last cleaned and disinfected; 3. have been subjected to ante-mortem and post-mortem examinations and have shown no signs suggestive of LPNAI;

(vi) Meat and meat preparations from Poultry (including turkeys): 4.B 4.C 5.B 5.C ND The [insert relevant commodity] herein described was derived from: 1. Animals from holdings free from ND and not situated in an ND protection or surveillance zone; AND EITHER 2*) have not been vaccinated against ND; OR 3*) were vaccinated against ND using a vaccine complying with the standards described in Commission Decision 93/152/EEC (the nature of the vaccine used and the date of vaccination shall also be stated in the certificate). AND 4. The animals showed no clinical sign of ND on the day of shipment to the slaughter house and were further subjected to ante-mortem and post-mortem examination and having showed no clinical signs suggestive of ND; were slaughtered in an approved establishment that is subject to regular inspection by the Veterinary Competent Authority and which has not processed poultry infected with ND since having last cleaned and disinfected.

(vii) Meat Products and other processed products derived from bi-ungulates including swine ( suidae ) and poultry (including turkeys): 6.A 6.B 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H FMD, CSF, SVD, ASF, RND, ND, LPNAI, HPNAI, PPR The [insert relevant commodity] herein described has been heat treated in a hermetically sealed container with an F0 value of 3,00 or more

(viii) Meat Products and other processed products derived from bi-ungulates including swine ( suidae ) and poultry (including turkeys): 6.A 6.B 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H FMD, CSF, SVD, RND, ND, LPNAI, HPNAI, PPR EITHER 1*) The [insert relevant commodity] herein described has been heat treated to a minimum temperature of 70 °C throughout the product. OR 2*) The [insert relevant commodity] herein described has been heat treated to 70 °C for minimum 30 minutes or an equivalent validated and approved thermal process.

(ix) Meat Products and other processed products derived from bi-ungulates including swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H FMD, CSF, SVD, ASF, RND, PPR The [insert relevant commodity] herein described has undergone heat treatment in a hermetically sealed container to at least 60 °C for a minimum of 4 hours, during which time the core temperature has reached at least 70 °C for 30 minutes.

(x) Meat Products and other processed products derived from swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H ASF The [insert relevant commodity] herein described has been heat treated to a minimum temperature of 80 °C throughout the product.

(xi) Meat Products and other processed products (boneless) derived from bi-ungulates including swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H FMD, CSF, SVD, ASF, RND The [insert relevant commodity] herein described is boneless and has undergone a natural fermentation and maturation process for not less than nine months resulting in the following characteristics: Aw value of not more than 0,93 or a pH value of not more than 6,0.

(xii) Meat Products and other processed products (including bone in) derived from bi-ungulates including swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H FMD, CSF, SVD The [insert relevant commodity] herein described which may contain bone has undergone a natural fermentation and maturation process for not less than nine months resulting in the following characteristics: Aw value of not more than 0,93 or a pH value of not more than 6,0.

(xiii) Meat Products and other processed products derived from bi-ungulates including swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H FMD, PPR The [insert relevant commodity] herein described has been heat treated to ensure a core temperature of at least 65 °C is reached for the time necessary to achieve a pasteurisation value (PV) equal to, or more than, 40.

(xiv) Meat Products and other processed products derived from swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H CSF The [insert relevant commodity] herein described is a dry cured pork meat1 and is; EITHER 1*) Bone-in Italian style pork ham that has been cured with salt and dried for a minimum of 313 days1; OR 2*) Bone-in Spanish style pork, Iberian shoulder, that has been cured with salt and dried for a minimum of 252 days1; OR 3*) Bone-in Spanish style pork, Iberian loin, that has been cured with salt and dried for a minimum of 126 days1; OR 4*) Bone-in Spanish style pork, Serrano ham, that has been cured with salt and dried for a minimum of 140 days1. Foot note 1: At the time of publication import conditions for pork meat into New Zealand may apply curing times exceeding the minimum stated for CSF.

(xv) Meat Products and other processed products derived from swine ( suidae ): 6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H ASF The [insert relevant commodity] herein described has been subject to treatment involving natural fermentation and maturation during at least 190 days for hams and 140 days for loins.

(xvi) Animal Casings derived from ruminants: 7.A 12.0 FMD The animal casings herein described have been cleaned, scraped and either salted with sodium chloride for 30 days or bleached or dried after scraping and were protected from recontamination after treatment.

(xvii) Processed (rendered) Animal Protein, lards, fats and petfood derived from ungulates and poultry (including turkeys): 15.0 17.0 21.0 FMD, SVD, RND, PPR, ASF, ND, LSD The [insert relevant commodity] herein described has been thermally treated in accordance with minimum regulatory standards and to a minimum 90 degrees Celsius for ten minutes throughout the product.

(xviii) Wool and fibre from ruminants: 20.0 FMD, RND EITHER 1*) The [insert relevant commodity] herein described has been stored at 18 °C for 4 weeks, or 4 °C for 4 months, or 37 °C for 8 days OR 2*) The [insert relevant commodity] herein described has been subject to industrial scouring by immersion in water soluble detergent at 60-70 °C. OR 3*) The unprocessed [insert relevant commodity] has been cleaned, dried and securely enclosed in packaging in accordance with the requirements of Regulation (EC) No 1069/2009

(xix) Treated Hides and Skins: 19 FMD, RND The hides or skins herein described have been salted for 7 days in sea salt containing at least 2 % sodium carbonate.

(xx) Treated Hides and Skins: 19 FMD EITHER 1*) The hides or skins herein described have been dry or wet salted for 14 days prior to dispatch and have been shipped by sea. OR 2*) The hides and skins herein described have been dried for 42 days at temperatures of at least 20 °C.

(xxii) Fully Treated Hides and Skins (wet blue, pickled, limed or hides that have completed the tanning process): 19 FMD, RND Fully treated hides and skins can be traded without restriction provided that these products have been submitted to the usual chemical and mechanical processes in use in the tanning industry. The following attestation may be applied in order to facilitate trade: The fully treated hides and skins described have been submitted to the usual chemical and mechanical processes in use in the tanning industry.

(xxiii) Bovine Semen: 1 FMD The semen herein described: EITHER 1*) was derived from donor animals which were kept in a semen collection centre where no animals have been added in last the 30 days before collection and FMD has not occurred within 10 kilometres for 30 days before and after collection, and which showed no clinical sign of FMD on the day of collection, have not been vaccinated against FMD and were subjected, not less than 21 days after collection of the semen, to a tests for antibodies against FMD virus, with negative results and no other animals present in the semen collection centre has been vaccinated against FMD. Additionally, the semen was collected from a semen collection centre not located within a protection or surveillance zone and any semen collected within a protection and surveillance zone has been clearly identified and detained under official supervision; and the semen collected, was further processed and stored in conformity with the provisions of Chapter 4.5 or Chapter 4.6 of the OIE Terrestrial Animal Health Code as relevant and was further stored in the country of origin for a period of at least one month following collection, and during this period no animal on the establishment where the donor animals were kept showed any sign of FMD. OR 2*) has been collected and stored frozen at least 21 days before the estimated date of earliest infection with the foot-and-mouth disease virus on a holding in the protection and surveillance zone; and any semen collected after the date of earliest infection has been stored separately and was only released after all the measures relating to the outbreak of FMD have been removed; and all animals accommodated in the semen collection centre have undergone a clinical examination and samples taken have been subjected to a serological test to substantiate the absence of infection in the centre concerned; and the donor animals have been subjected with negative result to a serological test for the detection of antibodies against the FMD virus on a sample taken not earlier than 28 days after the collection of the semen.

(xxiv) Bovine Semen: 1 BT The semen herein described was derived from donor animals: EITHER That were kept in a vector-protected establishment for at least 60 days before the commencement of, and during, collection of the semen; OR That were subjected to a serological test according to the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals to detect antibody to the BTV group, with negative results, at least every 60 days throughout the collection period and between 21 days and 60 days after the final collection for the consignment to be exported: OR That were subjected to an agent identification test according to the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on blood samples collected at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days (for PCR test) during, semen collection for the consignment to be exported, with negative results: OR The semen collection centre is not within an infected (restricted) zone. Semen from infected (restricted) zones has been clearly identified and detained under official supervision. AND The semen was collected, processed and stored in conformity with the OIE standards.

(xxv) Bovine Semen: 1 LSD The semen herein described was derived from donor animals: That showed no clinical sign of LSD on the day of collection of the semen and for the following 28 days; and the animals were kept in the exporting country for the 28 days prior to collection, in a semen collection centre where no case of LSD was officially reported during that period, and the centre was not situated in either a LSD infected zone or buffer zone and any semen from buffer zone has been clearly identified and controlled.

(xxvi) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida ): 2 FMD The in vivo derived embryos herein described were derived from donors that: Were free of clinical signs of FMD, at the time of collection; and from which the embryos were conceived by artificial insemination using semen collected, processed and stored in semen collection centres approved by the competent authority in conformity with OIE standards. In addition the embryos have been collected, processed and stored in accordance with standards laid down by the competent authority; AND The donor animals from which the embryos were collected originate from a herd(s) that was/were not located within a protection or surveillance zone. Embryos collected within the protection and surveillance zones have been clearly identified and detained under official supervision.

(xxvii) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida ): 2 BT The in vivo derived embryos herein described were derived from donors that: Were free of clinical signs of BT at the time of collection and from which the embryos were conceived by artificial insemination using semen collected, processed and stored in semen collection centres approved by the competent authority in conformity with the OIE standards. AND The embryos were collected, processed and stored in accordance with standards laid down by the competent authority.

(xxviii) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida ): 2 VS The in vivo derived embryos herein described were derived from donors that: Were kept for 21 days prior to, and during, collection in an establishment where no case of VS was reported during that period and were subject to a diagnostic test for VS, with negative results, within 21 days prior to embryo collection. In addition the embryos were collected, processed and stored in conformity with OIE notified standards; and the establishment was not located within a protection or surveillance zone. Embryos collected within protection and surveillance zones has been clearly identified and detained under official supervision.

(xxix) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida ): 2 CBPP The in vivo derived embryos herein described were derived from donors that: EITHER 1*) have not been vaccinated against CBPP and were subjected to the complement fixation test for CBPP with negative results, on two occasions, with an interval of not less than 21 days and not more than 30 days between each test, the second test being performed within 14 days prior to collection; and were isolated from other domestic bovidae from the day of the first complement fixation test until collection; OR 2*) were vaccinated using a vaccine complying with the standards described in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals not more than 4 months prior to collection; AND showed no clinical sign of CBPP on the day of collection of the embryos; and were kept since birth, or for the past 6 months, in a herd(s) where no case of CBPP was reported during that period, and that the herd(s) was/were not situated in a CBPP infected zone; and the embryos were collected, processed and stored in accordance with standards laid down by the competent authority.

(xxx) Poultry hatching eggs: 2 LPNAI, HPNAI — Notifiable in accordance with OIE Terrestrial Animal Health Code criteria Avian influenza (OIE notifiable) Newcastle disease For trade from the EU to NZ: The poultry hatching eggs herein described were derived from source flocks and hatcheries within a Ministry for Primary Industries approved compartment free of notifiable avian influenza [and/or] Newcastle disease [delete as appropriate]

(xxxi) Live bees/bumble bees: 3 Small hive beetle (Aethina tumida) For trade from NZ to the EU: (a) hives come from an area at least 100 km radius which is not subject to any restrictions associated with the suspicion or confirmed occurrence of the small hive beetle (Aethina tumida) and where these infestations are absent; (b) the bees/bumble bees (1) as well as their packaging have undergone a visual examination to detect the occurrence of the small hive beetle (Aethina tumida) or their eggs and larvae. (1) Delete as appropriate